PADIVAX
Live / Applied — Second extension granted (statement of use) (as of 22 Oct 2025)
What this means for you
Not registered yet, but its 17 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98318085
- Mark type
- Stylized text
- Filed
- 17 Dec 2023
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Ryan S. Hilbert
Goods and services
- Class 005 — Pharmaceuticals: Vaccine adjuvants; Vaccine preparations; Vaccines; Vaccines against viral infection; Vaccines for human use; Adjuvants for use with vaccines; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Human vaccine preparations; Therapeutic vaccines; Veterinary vaccines; Viral vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases
- Class 042 — Scientific and technological services: Vaccine research and development; Vaccine research and development services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical research in the fields of cancer and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies
Owner
- POP Biotechnologies, Inc., Buffalo, NY, US
- POP Biotechnologies, Inc., Buffalo, NY, US
Prosecution history
- 22 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2025 — SOU EXTENSION 2 GRANTED
- 21 Oct 2025 — SOU EXTENSION 2 FILED
- 21 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Apr 2025 — SOU EXTENSION 1 GRANTED
- 21 Apr 2025 — SOU EXTENSION 1 FILED
- 21 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jul 2024 — ASSIGNED TO EXAMINER
- 24 Mar 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED